VIP: Vascular Imaging Project. Prospective Randomized Study on the Effect of AUC-monitored Treatment With Steroids Combined With Either a Calcineurin Inhibitor or Mycophenolate Mofetil on the Progression of Subclinical Cardiovascular Disease in Renal Transplant Recipients.
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Ciclosporin (Primary) ; Corticosteroids (Primary) ; Mycophenolate mofetil (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Acronyms NICE; VIP
- 13 Dec 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT00169910).
- 05 Sep 2012 Results of cardiovascular substudy published in Transplantation.
- 04 May 2011 Results of main study presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.